pI: 6.9139 |
Length (AA): 811 |
MW (Da): 91013 |
Paralog Number:
2
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Ortholog group members (OG5_131104)
Species | Accession | Gene Product |
---|---|---|
Brugia malayi | Bm1_50265 | Protein kinase domain containing protein |
Candida albicans | CaO19.5376 | Serine/threonine protein kinase |
Candida albicans | CaO19.3068 | DNA polymerase alpha suppressing protein kinase. |
Candida albicans | CaO19.12831 | Serine/threonine protein kinase |
Caenorhabditis elegans | CELE_Y59A8B.14 | Protein PAR-4, isoform B |
Dictyostelium discoideum | DDB_G0279629 | CAMKL family protein kinase |
Drosophila melanogaster | Dmel_CG9374 | CG9374 gene product from transcript CG9374-RE |
Homo sapiens | ENSG00000118046 | serine/threonine kinase 11 |
Loa Loa (eye worm) | LOAG_03149 | CAMK/CAMKL/LKB protein kinase |
Mus musculus | 20869 | serine/threonine kinase 11 |
Schmidtea mediterranea | mk4.002570.00 | Serine/threonine-protein kinase par-4 |
Trichomonas vaginalis | TVAG_319990 | CAMK family protein kinase |
Trichomonas vaginalis | TVAG_351980 | CAMK family protein kinase |
Trichomonas vaginalis | TVAG_374000 | CAMK family protein kinase |
Trichomonas vaginalis | TVAG_425830 | CAMK family protein kinase |
Trichomonas vaginalis | TVAG_032510 | CAMK family protein kinase |
Trichomonas vaginalis | TVAG_404110 | CAMK family protein kinase |
Trichomonas vaginalis | TVAG_192890 | CAMK family protein kinase |
Trichomonas vaginalis | TVAG_388270 | CAMK family protein kinase |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Homo sapiens | serine/threonine kinase 11 | Compounds | References |